Company / Current Liabilities per Share
Dexcom Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$5.57
FY2025
5-year range
$4.04 / $7.50
FY2021-FY2025
Trend
-25.8%
vs FY2024
Sector context
#74 of 158
Health Care
What the data says
At $5.57, Dexcom's current liabilities per share ranks #85 of 158 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $1.25 in FY2016 to $7.50 in FY2024.
Based on SEC 10-K filings.
5.57 in FY2025 with a 5-year CAGR of -2.7%.
Increased from $4.04 to $5.57 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +5.5%
- 5-Year CAGR
- -2.7%
- 10-Year CAGR
- -
Sector benchmark
#85 of 158 in Health CareTop 53% of 158This company $5.57 Sector average $29.89
▼
-81.4% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 25.8% year-over-year.
- Ranks #74 out of 158 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2024.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.57 | -25.8% |
| FY2024 | $7.50 | +85.9% |
| FY2023 | $4.04 | -14.8% |
| FY2022 | $4.74 | -36.8% |
| FY2021 | $7.50 | +17.4% |
| FY2020 | $6.39 | +62.5% |
| FY2019 | $3.93 | +53.8% |
| FY2018 | $2.56 | +55.7% |
| FY2017 | $1.64 | +31.0% |
| FY2016 | $1.25 | +44.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026